Skip to main content

Advertisement

Log in

Successful treatment of autoimmune lymphoproliferative syndrome and refractory autoimmune thrombocytopenic purpura with a reduced intensity conditioning stem cell transplantation followed by donor lymphocyte infusion

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Worth A, Thrasher AJ, Gaspar HB . Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype. Br J Haematol 2006; 133: 124–140.

    Article  CAS  PubMed  Google Scholar 

  2. Straus SE, Sneller M, Lenardo MJ, Puck JM, Strober W . An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med 1999; 130: 591–601.

    Article  CAS  PubMed  Google Scholar 

  3. Sneller MC, Wang J, Dale JK, Strober W, Middelton LA, Choi Y et al. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 1997; 89: 1341–1348.

    CAS  PubMed  Google Scholar 

  4. Rieux-Laucat F, Le Deist F, Fischer A . Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ 2003; 10: 124–133.

    Article  CAS  PubMed  Google Scholar 

  5. Poppema S, Maggio E, van den Berg A . Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations. Leuk Lymphoma 2004; 45: 423–431.

    Article  CAS  PubMed  Google Scholar 

  6. Chakraverty R, Peggs K, Chopra R, Milligan DW, Kottaridis PD, Verfuerth S et al. Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. Blood 2002; 99: 1071–1078.

    Article  CAS  PubMed  Google Scholar 

  7. Sleight BJ, Prasad VS, DeLaat C, Steele P, Ballard E, Arceci RJ et al. Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation. Bone Marrow Transplant 1998; 22: 375–380.

    Article  CAS  PubMed  Google Scholar 

  8. Benkerrou M, Le Deist F, de Villartay JP, Caillat-Zucman S, Rieux-Laucat F, Jabado N et al. Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation. Eur J Immunol 1997; 27: 2043–2047.

    Article  CAS  PubMed  Google Scholar 

  9. Vacek MM, Schaffer AA, Davis J, Fischer RE, Dale JK, Adams S et al. HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia). Clin Immunol 2006; 118: 59–65.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P D Kottaridis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dimopoulou, M., Gandhi, S., Ghevaert, C. et al. Successful treatment of autoimmune lymphoproliferative syndrome and refractory autoimmune thrombocytopenic purpura with a reduced intensity conditioning stem cell transplantation followed by donor lymphocyte infusion. Bone Marrow Transplant 40, 605–606 (2007). https://doi.org/10.1038/sj.bmt.1705775

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705775

  • Springer Nature Limited

This article is cited by

Navigation